دورية أكاديمية
أعرض في EDS

The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma.

التفاصيل البيبلوغرافية
العنوان: The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma.
المؤلفون: Panayotova G; Rutgers New Jersey Medical School, Department of Surgery, Division of Transplant and HPB Surgery, Newark, NJ 07103, USA., Guerra J; Rutgers New Jersey Medical School, Department of Surgery, Division of Transplant and HPB Surgery, Newark, NJ 07103, USA., Guarrera JV; Rutgers New Jersey Medical School, Department of Surgery, Division of Transplant and HPB Surgery, Newark, NJ 07103, USA., Lunsford KE; Rutgers New Jersey Medical School, Department of Surgery, Division of Transplant and HPB Surgery, Newark, NJ 07103, USA.
المصدر: Journal of clinical medicine [J Clin Med] 2021 May 30; Vol. 10 (11). Date of Electronic Publication: 2021 May 30.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2012]-
مستخلص: Intrahepatic cholangiocarcinoma (iCCA) is a rare and complex malignancy of the biliary epithelium. Due to its silent presentation, patients are frequently diagnosed late in their disease course, resulting in poor overall survival. Advances in molecular profiling and targeted therapies have improved medical management, but long-term survival is rarely seen with medical therapy alone. Surgical resection offers a survival advantage, but negative oncologic margins are difficult to achieve, recurrence rates are high, and the need for adequate future liver remnant limits the extent of resection. Advances in neoadjuvant and adjuvant treatments have broadened patient treatment options, and these agents are undergoing active investigation, especially in the setting of advanced, initially unresectable disease. For those who are not able to undergo resection, liver transplantation is emerging as a potential curative therapy in certain cases. Patient selection, favorable tumor biology, and a protocolized, multidisciplinary approach are ultimately necessary for best patient outcomes. This review will discuss the current surgical management of locally advanced, liver-limited intrahepatic cholangiocarcinoma as well as the role of liver transplantation for select patients with background liver disease.
References: Am J Surg. 1993 Dec;166(6):768-71; discussion 771-2. (PMID: 8273866)
Hepatology. 2016 Oct;64(4):1178-88. (PMID: 27481548)
Radiat Oncol. 2019 Dec 27;14(1):241. (PMID: 31881895)
Ann Surg Oncol. 2019 Jun;26(6):1841-1850. (PMID: 30843164)
Lancet. 2014 Jun 21;383(9935):2168-79. (PMID: 24581682)
Cancer Control. 2018 Jan-Mar;25(1):1073274817744621. (PMID: 29327594)
Hepatology. 2021 Jun;73(6):2311-2325. (PMID: 33073396)
Dig Dis Sci. 2015 Nov;60(11):3226-9. (PMID: 25824976)
Oncology. 2018;94(2):72-78. (PMID: 29017161)
Medicine (Baltimore). 2018 Aug;97(34):e11999. (PMID: 30142840)
Medicine (Baltimore). 2019 Feb;98(5):e14013. (PMID: 30702559)
Hepatology. 2017 May;65(5):1777-1778. (PMID: 27997682)
Ann Surg Oncol. 2009 Nov;16(11):3048-56. (PMID: 19626372)
Surgery. 2009 Apr;145(4):411-6. (PMID: 19303990)
Medicine (Baltimore). 2019 Dec;98(49):e18191. (PMID: 31804337)
Cancer Control. 2017 Jul-Sep;24(3):1073274817729241. (PMID: 28975832)
Jpn J Surg. 1989 Jan;19(1):98-129. (PMID: 2659865)
Ann Surg. 2007 May;245(5):755-62. (PMID: 17457168)
Arch Surg. 2011 Mar;146(3):348-56. (PMID: 21079109)
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. (PMID: 32606456)
J Surg Oncol. 2019 Mar;119(3):288-294. (PMID: 30586170)
Surg Endosc. 2016 Nov;30(11):4835-4840. (PMID: 26902611)
Curr Oncol Rep. 2020 Apr 16;22(5):49. (PMID: 32297105)
World J Surg. 1995 Nov-Dec;19(6):807-13. (PMID: 8553670)
Liver Int. 2008 Jul;28(6):767-80. (PMID: 18647141)
Chin Clin Oncol. 2018 Oct;7(5):53. (PMID: 30180752)
Gastroenterol Clin North Am. 2018 Jun;47(2):267-280. (PMID: 29735023)
Ann Surg. 2018 May;267(5):797-805. (PMID: 29064885)
J Gastrointest Surg. 2008 Jan;12(1):117-22. (PMID: 17963015)
J Clin Oncol. 2019 Apr 20;37(12):1015-1027. (PMID: 30856044)
Hepatobiliary Surg Nutr. 2017 Apr;6(2):79-90. (PMID: 28503555)
J Hepatol. 2020 Feb;72(2):364-377. (PMID: 31954498)
JAMA Oncol. 2020 Sep 1;6(9):1405-1409. (PMID: 32729929)
PLoS One. 2019 Jul 31;14(7):e0220527. (PMID: 31365594)
Liver Transpl. 2020 Jun;26(6):785-798. (PMID: 32090444)
Lancet Oncol. 2019 May;20(5):663-673. (PMID: 30922733)
Ann Surg. 2009 Feb;249(2):303-9. (PMID: 19212186)
Surg Endosc. 2003 Dec;17(12):1914-8. (PMID: 14574547)
Liver Int. 2019 May;39 Suppl 1:19-31. (PMID: 30851228)
J Gastrointest Surg. 2017 Nov;21(11):1841-1850. (PMID: 28744741)
World J Hepatol. 2016 Mar 28;8(9):439-45. (PMID: 27028706)
Br J Surg. 2000 Jul;87(7):879-82. (PMID: 10931022)
J Hepatol. 2017 Sep;67(3):632-644. (PMID: 28389139)
Ann Surg. 2010 Jul;252(1):107-14. (PMID: 20531002)
Transplantation. 2020 Jun;104(6):1119-1120. (PMID: 32217941)
Ann Surg. 1996 Nov;224(5):628-38. (PMID: 8916878)
HPB (Oxford). 2016 May;18(5):419-27. (PMID: 27154805)
J Natl Compr Canc Netw. 2021 May 1;19(5):541-565. (PMID: 34030131)
J Hepatol. 2020 Feb;72(2):353-363. (PMID: 31954497)
J Am Coll Surg. 2001 Oct;193(4):384-91. (PMID: 11584966)
Ann Surg. 2011 Nov;254(5):824-29; discussion 830. (PMID: 22042474)
JAMA Oncol. 2019 Jun 01;5(6):824-830. (PMID: 30998813)
World J Surg. 2007 Oct;31(10):2016-22. (PMID: 17687597)
HPB (Oxford). 2015 Aug;17(8):669-80. (PMID: 26172134)
J Gastrointest Surg. 2018 Jan;22(1):52-59. (PMID: 28424987)
Cardiovasc Intervent Radiol. 2020 Sep;43(9):1305-1314. (PMID: 32642986)
Surg Oncol Clin N Am. 2009 Apr;18(2):289-305, viii-ix. (PMID: 19306813)
PLoS One. 2016 Jun 08;11(6):e0156127. (PMID: 27276221)
Hepatobiliary Surg Nutr. 2017 Feb;6(1):7-21. (PMID: 28261591)
Br J Surg. 2001 Nov;88(11):1463-6. (PMID: 11683741)
Pathol Oncol Res. 2020 Jan;26(1):3-15. (PMID: 30448973)
J Surg Oncol. 2020 Apr;121(5):863-872. (PMID: 31902142)
Gan To Kagaku Ryoho. 2016 Nov;43(12):1764-1766. (PMID: 28133124)
Surg Oncol Clin N Am. 2019 Oct;28(4):587-599. (PMID: 31472907)
JAMA Surg. 2020 Sep 1;155(9):823-831. (PMID: 32639548)
Ann Transplant. 2015 Jun 30;20:366-72. (PMID: 26124187)
J Gastrointest Surg. 2018 Apr;22(4):668-675. (PMID: 29264768)
J Natl Cancer Inst. 2020 Feb 1;112(2):200-210. (PMID: 31077311)
ANZ J Surg. 2017 Jan;87(1-2):22-27. (PMID: 27647697)
Dig Endosc. 2019 Jul;31(4):439-447. (PMID: 30714216)
Cancer. 2020 Jun 1;126(11):2666-2678. (PMID: 32129902)
Clin J Gastroenterol. 2009 Oct;2(5):351-354. (PMID: 26192612)
Ann Surg Oncol. 2015 Jul;22(7):2218-25. (PMID: 25354576)
Surgery. 2019 Dec;166(6):975-982. (PMID: 31421869)
World J Hepatol. 2020 Oct 27;12(10):693-708. (PMID: 33200010)
Liver Transpl. 2001 Dec;7(12):1023-33. (PMID: 11753904)
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):669-676. (PMID: 30374530)
Chin Clin Oncol. 2018 Oct;7(5):52. (PMID: 30180751)
Transplantation. 2000 Apr 27;69(8):1633-7. (PMID: 10836374)
Br J Surg. 2018 Jun;105(7):839-847. (PMID: 28858392)
Int Cancer Conf J. 2018 May 18;7(3):93-97. (PMID: 31149523)
Surgery. 2014 Sep;156(3):538-47. (PMID: 25017135)
J Clin Oncol. 2019 Mar 10;37(8):658-667. (PMID: 30707660)
Transpl Int. 2008 Dec;21(12):1107-17. (PMID: 18713148)
Arch Surg. 2002 Jun;137(6):675-80; discussion 680-1. (PMID: 12049538)
HPB Surg. 2013;2013:657309. (PMID: 23861556)
Hepatol Res. 2007 Sep;37(9):676-91. (PMID: 17617112)
J Surg Oncol. 2021 Mar;123(4):949-956. (PMID: 33400841)
JAMA. 2012 Jul 11;308(2):147-56. (PMID: 22782416)
Arch Surg. 2011 Jun;146(6):683-9. (PMID: 21690444)
J Cancer Res Clin Oncol. 2010 Sep;136(9):1323-31. (PMID: 20130909)
Liver Int. 2014 Jul;34(6):953-60. (PMID: 24134199)
Hepatobiliary Surg Nutr. 2017 Feb;6(1):22-34. (PMID: 28261592)
Clin Cancer Res. 2016 Jan 15;22(2):291-300. (PMID: 26405193)
Ann Surg. 2014 May;259(5):944-52. (PMID: 24441817)
Lancet Gastroenterol Hepatol. 2018 May;3(5):337-348. (PMID: 29548617)
Ann Surg Oncol. 2015 Aug;22(8):2772-8. (PMID: 25663595)
Cancer. 2002 Oct 15;95(8):1685-95. (PMID: 12365016)
J Gastroenterol. 2015 Sep;50(9):913-27. (PMID: 25833009)
Ann Surg Oncol. 2020 May;27(5):1372-1384. (PMID: 32002719)
Surg Endosc. 2016 May;30(5):1999-2010. (PMID: 26194257)
Oncologist. 2015 Jun;20(6):640-7. (PMID: 25956404)
Cancer Med. 2020 Apr;9(8):2674-2685. (PMID: 32072774)
Hepatobiliary Surg Nutr. 2017 Apr;6(2):101-104. (PMID: 28503557)
Transplantation. 2020 Jun;104(6):1125-1130. (PMID: 32217937)
Liver Transpl. 2018 May;24(5):634-644. (PMID: 29514406)
Langenbecks Arch Surg. 2019 Nov;404(7):885-894. (PMID: 31734715)
J Gastroenterol. 2013 May;48(5):647-59. (PMID: 23001251)
Br J Surg. 2018 Jun;105(7):857-866. (PMID: 29656380)
Ann Surg Oncol. 2020 Oct;27(10):3729-3737. (PMID: 32472411)
Ann Surg. 2005 Sep;242(3):451-8; discussion 458-61. (PMID: 16135931)
J Clin Oncol. 2011 Aug 10;29(23):3140-5. (PMID: 21730269)
Acta Oncol. 2018 Jun;57(6):807-812. (PMID: 29265948)
Ann Surg Oncol. 2013 Jan;20(1):318-24. (PMID: 23149849)
J Clin Oncol. 2013 Mar 20;31(9):1188-95. (PMID: 23358969)
Liver Int. 2019 May;39 Suppl 1:98-107. (PMID: 30831002)
Hepatology. 2011 Jul;54(1):173-84. (PMID: 21488076)
Eur J Surg Oncol. 2017 Sep;43(9):1617-1621. (PMID: 28292628)
فهرسة مساهمة: Keywords: biliary tract malignancy; cholangiocarcinoma; intrahepatic cholangiocarcinoma; liver resection; liver transplantation; transplant oncology
تواريخ الأحداث: Date Created: 20210602 Latest Revision: 20240402
رمز التحديث: 20240402
مُعرف محوري في PubMed: PMC8199311
DOI: 10.3390/jcm10112428
PMID: 34070772
قاعدة البيانات: MEDLINE
الوصف
تدمد:2077-0383
DOI:10.3390/jcm10112428